| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| MITOTANE
| MITOTANE | ANTINEOPLASTIC | ORAL | Cmax 44.7 MICROMOLAR F 40 PERCENT HT 2124 HOUR | SXR RECEPTOR | CYTOCHROME P450 11A1 INHIBITOR CHEMBL2033 CYTOCHROME P450 11A1 P05108 CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME, MITOCHONDRIAL HOMO SAPIENS ENZYME CYTOCHROME P450 CYP_11 CYP_11A CYP_11A1 | EMA | |||
